Leading the way to safer medication
 Crosscheck  Recommender

Metoprolol

Description

Metoprolol is a cardioselective beta-adrenergic blocking agent. It has a relatively greater blocking effect on beta1-receptors (ie those mediating adrenergic stimulation of heart rate and contractility and release of free fatty acids from fat stores) than on beta2-receptors, which are chiefly involved in broncho and vasodilation.

ATC Classification

Code
Title
Category
C07AB02
Metoprolol
C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective

Trade names

Trade name
Countries
BELOC

Austria

BELOKEN

Spain

BETALOC

Australia Cyprus United Kingdom

BLOXAZOC

Cyprus

CARDOXONE

Cyprus

DENEX

Cyprus Singapore

KAPSPARGO

United States

LANOC

Austria

LOPRESOR

Australia Canada Spain

LOPRESSOR

France United States

METOHEXAL

Austria

METROL

Australia

MINAX

Australia

MISTROM

Australia

SELOKEEN

Netherlands

SELOKEN

Austria France

SELOZOK

France

TOPROL XL

Australia United States

Trade names (in combination): DUTOPROL IMPLICOR LOGIMAX SELOKOMB

Product Monographs

Monograph
Type
Country
BETALOC Solution for injection
MPI, EU: SmPC
UK
TOPROL XL Extended-release tablet
MPI, US: SPL/PLR
US
METOPROLOL TARTRATE Tablet
MPI, EU: SmPC
UK

2D Molecule Structure

Unique Ingredient Identifier (UNII)

GEB06NHM23 - METOPROLOL

CAS Registry Number

51384-51-1 - metoprolol

SNOMED-CT

372826007 - Metoprolol (substance)

 
Next: Usage >